|
|
|
|
| |
| |
June 11, 2010 |
|
| |
Corporate Presentation at Annual Meeting of Shareholders 2010
by Michael West, CEO BioTime, Inc |
|
| |
June 10, 2010 |
|
| |
BioTime Forms New Subsidiary, OrthoCyte Corporation, to Develop Treatments for Orthopedic
Conditions Using Stem Cell Technology
|
|
| |
June 9, 2010 |
|
| |
BioTime CEO Dr. Michael West's Presentation to the Inaugural Jefferies Global Life Sciences Conference
Webcast Link |
|
| |
May 27, 2010 |
|
| |
Fate Space Screening of Clonal Human ES-DerIved Embryonic Progenitor Cell Lines for Chondrogenesis, GTCbio 6th Stem Cell Research & Therapeutics... By Michael West, May 27, 2010 |
|
| |
May 3, 2010 |
|
| |
BioTime, Inc. Announces Completion of ES Cell International Pte Ltd Acquisition |
|
| |
April 29, 2010 |
|
| |
BioTime, Inc. Provides Additional Information on Acquisition of Promissory Notes in Connection with Planned Acquisition of ES Cell International Pte Ltd. |
|
| |
April 29, 2010 |
|
| |
BioTime, Inc. Announces Agreement to Acquire ES Cell International
|
|
| |
March 16, 2010 |
|
| |
|
|
| |
March 16, 2010 |
|
| |
|
|
| |
March 16, 2010 |
|
| |
|
|
| |
February 11, 2010 |
|
| |
|
|
|
|
|
|
